Pharmaceutical

Merck to invest €300m in South Korean bioprocessing centre

Merck KGaA has announced an investment of over €300m ($326.1m) to establish a new bioprocessing production centre in Daejeon, South Korea.

Mar 22, 2024 - 00:00
Merck to invest €300m in South Korean bioprocessing centre
Merck KGaA has announced an investment of over €300m ($326.1m) to establish a new bioprocessing production centre in Daejeon, South Korea.
Read the original article

Tags:

Previous Article

Delivery tech remains challenging with gene therapies for brain disorders

Next Article

Donanemab: FDA AdCom will put spotlight on tau enrolment and ARIA concerns

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Medicare Advantage plans will have to stop denying required care, federal officials say

STAT+: Medicare Advantage plans will have to stop denyi...

Apr 5, 2023

Gilead’s Tecartus escapes harsher classwide boxed warning for CAR-T therapies

Gilead’s Tecartus escapes harsher classwide boxed warni...

Jan 25, 2024

STAT+: Alkermes shareholders re-elect directors, rebuffing effort by hedge fund Sarissa

STAT+: Alkermes shareholders re-elect directors, rebuff...

Jun 30, 2023